CorMedix Inc.CRMDNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+79.4%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
+79.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
18.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 390.40% |
| 2024 | -70.03% |
| 2023 | 23.18% |
| 2022 | -18.68% |
| 2021 | -1.83% |
| 2020 | 21.03% |
| 2019 | -41.28% |
| 2018 | -23.13% |
| 2017 | 55.61% |
| 2016 | 150.49% |